FT

Vaccitech warns of blood clot risk in IPO filing

Oxford university spinout behind AstraZeneca Covid-19 jab pushes ahead with US listing

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button